Meditech Technologies India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 136.54%
(FY 2021)
- Profit 94.29%
(FY 2021)
- Ebitda -3.00%
(FY 2021)
- Net Worth 28.08%
(FY 2021)
- Total Assets 33.01%
(FY 2021)
About Meditech Technologies India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Lubaina Ujjainwala and Mubaraka Sinnarwala serve as directors at the Company.
- CIN/LLPIN
U29221MH2013PTC245234
- Company No.
245234
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2013
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Meditech Technologies India Private Limited offer?
Meditech Technologies India Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems, Hospital and Medical Furniture, Hospital Chair, Plasma Freezer, Laboratory Chamber, Plant Growth Chambers, Blood Bank Refrigerators, Blood Bank Equipments, Blood Collection Mixer.
Who are the key members and board of directors at Meditech Technologies India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lubaina Ujjainwala  | Director | 05-Jul-2013 | Current |
| Mubaraka Sinnarwala | Director | 05-Jul-2013 | Current |
Financial Performance of Meditech Technologies India.
Meditech Technologies India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 136.54% increase. The company also saw a substantial improvement in profitability, with a 94.29% increase in profit. The company's net worth Soared by an impressive increase of 28.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meditech Technologies India?
In 2021, Meditech Technologies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meditech Technologies India?
Unlock and access historical data on people associated with Meditech Technologies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditech Technologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditech Technologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
